Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Breaking & Recent News XWELL Inc XWEL

XWELL, Inc. is a global health and wellness holding company. The Company operates through four segments: XpresTest, XpresSpa, Treat, and Naples Wax Center. The XpresTest segment provides diagnostic COVID-19 tests at XpresCheck Wellness Centers in airports, to airport employees and to the traveling public but has transitioned to the centers for disease control and prevention (CDC’s) bio... see more

Recent & Breaking News (NDAQ:XWEL)

XpresSpa Group Opens XpresCheck(TM) COVID-19 Testing Facility at Logan International Airport in Boston Today

GlobeNewswire October 28, 2020

XpresSpa Group Announces Expansion of Health and Wellness Services Beyond COVID-19 Testing

GlobeNewswire October 26, 2020

XpresSpa Group Begins Construction of New XpresCheck(TM) COVID-19 Testing Facility at Logan International Airport in Boston

GlobeNewswire October 9, 2020

XpresCheck(TM) Provides Business Update

GlobeNewswire October 6, 2020

XpresSpa Group Announces $35.3 Million Registered Direct Offering Priced At-The-Market under Nasdaq Rules

GlobeNewswire August 26, 2020

XpresCheck(TM) Shatters the Time Barrier in Airport COVID-19 Testing

GlobeNewswire August 24, 2020

XpresSpa Group Announces the Opening of XpresCheck(TM) COVID-19 Testing Facility at Newark Liberty International Airport's Terminal B on August 17, 2020

GlobeNewswire August 20, 2020

XpresSpa Group Provides Business Update and Announces Second Quarter 2020 Financial Results

GlobeNewswire August 19, 2020

XpresSpa Group to Provide Business Update and Announce Second Quarter 2020 Financial Results on August 19, 2020

GlobeNewswire August 14, 2020

XpresSpa Group Signs Contract with the Port Authority of New York and New Jersey for an XpresCheck(TM) COVID-19 Testing Facility at Newark Liberty International Airport

GlobeNewswire August 13, 2020

XpresSpa Group Announces Dismissal of Purported Derivative Lawsuit Filed by Moreton Binn and Marisol Binn against the Company and Certain Current and Former Directors

GlobeNewswire August 11, 2020

XpresSpa Group Provides Business Update

GlobeNewswire July 6, 2020

XpresSpa Group Announces the Opening of the XpresCheck(TM) Pilot Program for Airport Employees at JFK International Airport's Terminal 4; The First Full Service, In-Airport, Testing Facility in the U.S.

GlobeNewswire June 29, 2020

XpresSpa Group Announces $40 Million Registered Direct Offering Priced At-The-Market under Nasdaq Rules

GlobeNewswire June 17, 2020

XpresSpa Announces 1-for-3 Reverse Stock Split

GlobeNewswire June 10, 2020

XpresSpa Group Signs Contract with HyperPointe(TM) for Airport-based COVID-19 Screening and Testing

GlobeNewswire June 5, 2020

XpresSpa Signs Contract with JFK International Air Terminal LLC for COVID-19 Screening and Testing Location

GlobeNewswire May 22, 2020

XpresSpa Appoints Doctor Lewis Lipsey as First Chief Medical Director for Its XpresTest Subsidiary

GlobeNewswire April 13, 2020

XpresSpa Appoints Michael Lebowitz to Board of Directors

GlobeNewswire April 7, 2020

XpresSpa Group Announces Pricing of $3.05 Million Registered Direct Offering Priced At-The-Market

GlobeNewswire April 6, 2020